ELPEN focuses its research efforts on three major areas. Specifically:
1) The development of
- Generic preparations
- Incremental innovation pharmaceutical preparations
With research activities carried out both internally and in collaboration with specialized Greek and international companies, ELPEN focuses on the development of products with alternative pharmaceutical forms, as well as on innovative product combinations that provide substantial benefit for patients and healthcare systems.
In particular, ELPEN has a long-standing presence in the development of products in solid forms (tablets, capsules) across multiple therapeutic categories, as well as significant activity in the area of dry powder inhalers as a means of administering active substances and combinations of active substances. The company's research work in this area began in 2003, resulting in the development of the innovative Elpenhaler® inhaler. Furthermore, ELPEN is expanding its activity in the area of inhaled therapies by developing liquid nasal preparations as well as inhaled therapies in the form of liquids for inhalation under pressure using propellant gases with a low environmental footprint in full compliance with the new European requirements.
2) The field of Experimental Biomedical (Translational) Research and Training
The company focuses on in vivo experiments, translational research, as well as continuing scientific and medical training. Specifically, the company has a Research-Experimental and Training Center since 1996, which is currently recognized as the largest private laboratory for Experimental-Applied Biomedical Research and Training in Greece and the greater region of Southeastern Europe. At the same time, it is the only Greek training center for clinical and professional skills officially accredited by the UEMS-NASCE (European Union of Medical Specialists and Network of Accredited Clinical Skills Centers in Europe). At the ELPEN’s
Research - Experimental Center, numerous experimental PhD dissertations and Master’s theses have been prepared. Research proposals originate from both the Universities and the National Health System or from research ideas within the Center itself.
3) The field of Education
ELPEN maintains long-term partnerships with universities in Greece and abroad to support research programs of high scientific interest for both the company and society. It also actively participates in funded programs for the respiratory system, and has a dynamic presence in international conferences related to the technologies within its field of activity, as well as new technologies of the future (in the area of inhaled medicines: DDL - Drug Delivery to the Lungs, RDD – Respiratory Drug Delivery, and others).